Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/04/2012WO2012131347A1 Usnic acid topical formulation
10/04/2012WO2012131341A2 Tight junctions modulators
10/04/2012WO2012131297A1 Pyrido [3',2' :4,5] thieno [3, 2-d] pyrimidin- 4 - ylamine derivatives and their therapeutical use
10/04/2012WO2012131145A1 Serum cholesterol lowering drink and an improved method for lowering cholesterol
10/04/2012WO2012131142A1 Use of sulphamide derivatives as neuroprotectors
10/04/2012WO2012131134A1 Use of a non-coding region of the genome of the foot-and-mouth virus for the purpose of producing an antiviral drug
10/04/2012WO2012131096A1 Novel heterocyclic compounds as modulators of sphingolipid signaling and uses thereof
10/04/2012WO2012131090A1 Method for treatment of xeroderma pigmentosum
10/04/2012WO2012131084A1 Triaryl- and triheteroaryl- benzene monomers and polymers
10/04/2012WO2012131080A1 Aminoquinoxaline derivatives for treatment of neurodegenerative diseases
10/04/2012WO2012131079A1 Compounds inhibiting galectin-1 expression, cancer cell proliferation, invasion, and tumorigenesis
10/04/2012WO2012131077A1 Somatostatin mimetics
10/04/2012WO2012131069A1 Short chain fatty acids and their derivatives for use in treatment immunogenic disorders
10/04/2012WO2012131048A1 Treatment and prognosis of solid tumour cancers
10/04/2012WO2012131035A1 Composition comprising docetaxel
10/04/2012WO2012131010A1 Total synthesis of redox-active 1.4-naphthoquinones and their metabolites and their therapeutic use as antimalarial and schistomicidal agents
10/04/2012WO2012131005A1 Pharmaceutical composition of sitagliptin
10/04/2012WO2012131003A1 Trpm5 inhibitors support body weight reduction without reducing food intake
10/04/2012WO2012130996A1 Alisporivir to treat hepatitis c virus infection
10/04/2012WO2012130955A1 Prevention of hypoglycaemia in diabetes mellitus type 2 patients
10/04/2012WO2012130951A1 Aptamers that are specific for immunoglobulin-binding cell wall proteins
10/04/2012WO2012130915A1 Spiroalkene carboxamide derivatives and their use as chemokine receptor modulators
10/04/2012WO2012130912A1 Compounds for treatment of metabolic syndrome
10/04/2012WO2012130911A1 Bifunctional hydroxy-bisphosphonic acid derivatives
10/04/2012WO2012130906A1 Derivatives useful for the treatment or prevention of bone tumors
10/04/2012WO2012130905A1 Substituted benzimidazoles
10/04/2012WO2012130893A1 Use of epigallocatechin gallate as an antiviral agent against infections by the hepatitis c virus
10/04/2012WO2012130882A1 Fe(iii) complexes for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anaemias
10/04/2012WO2012130862A1 Selection of hcv treatment
10/04/2012WO2012130850A1 Tissue targeting by means of oncocidal bridged diphenyl derivatives for the selective treatment of sexual organ tumors
10/04/2012WO2012130837A1 Solid agomelatine in non-crystalline form
10/04/2012WO2012130829A1 New boranophosphate analogues of cyclic nucleotides
10/04/2012WO2012130821A1 Benzoic acid salt of otamixaban
10/04/2012WO2012130819A1 Otamixaban formulations with improved stability
10/04/2012WO2012130780A1 Thiazolopyrimidine compounds
10/04/2012WO2012130753A1 Process for the preparation of chondroitin sulfated at position 3 of glucuronic acid
10/04/2012WO2012130698A1 Composition comprising a diindolylmethane and a retinoid to treat a skin condition
10/04/2012WO2012130679A1 New azaspirodecanone compounds as hsl inhibitors
10/04/2012WO2012130646A1 N-acetyl-l-cysteine for the treatment of dysmenorrhea
10/04/2012WO2012130633A1 Pyrazole compounds as crth2 antagonists
10/04/2012WO2012130627A1 Nutritional compositions for increasing arginine levels and methods of using same
10/04/2012WO2012130621A1 Use of cationic surfactants against acne
10/04/2012WO2012130609A1 New combination comprising n-acetyl-l-cysteine and its use
10/04/2012WO2012130481A1 INHIBITION OF NF-kB ACTIVITY BY TRITERPENE COMPOUNDS
10/04/2012WO2012130448A1 A molecular scaffold to modulate thrombin/antithrombin activity by heparin binding
10/04/2012WO2012130322A1 Imidazo [1,2-a]pyridine compounds for use in therapy
10/04/2012WO2012130314A1 Composition comprising docetaxel
10/04/2012WO2012130306A1 Bicyclic 2,3-dihyrdobenzazine compounds for use in therapy
10/04/2012WO2012130299A1 Peptidase inhibitors
10/04/2012WO2012130183A1 [1,3,4] oxadiazole derivative and application thereof
10/04/2012WO2012130166A1 1-(arylmethyl)quinazoline-2,4(1h,3h)-diones as parp inhibitors and the use thereof
10/04/2012WO2012130160A1 Aminopyridine derivatives containing acridine ring and use thereof
10/04/2012WO2012130159A1 Aminopyridine derivatives and uses thereof
10/04/2012WO2012130153A1 Quinolinone derivatives and use thereof as medicament against schizophrenia
10/04/2012WO2012130141A1 Method and composition for enhancing target cells uptake of therapeutic agents
10/04/2012WO2012130116A1 Compound preparation treating alzheimer's disease and preparation method thereof
10/04/2012WO2012130114A1 Screening model for blockers of interaction between ribosomal proteins l12 and l10 of tubercle bacillus and use thereof
10/04/2012WO2012129967A1 New aminopyridine compounds, the preparation method, the pharmaceutical compositions comprising these compounds and the uses thereof
10/04/2012WO2012129966A1 Paeoniflorin compound having inhibitory activity on abnormal expression of cyclooxygenase-2, preparation method therefor, and use thereof
10/04/2012WO2012129957A1 Several pharmaceutical formulations
10/04/2012WO2012129942A1 Chiral 3-hydroxypyrid-4-one derivative, and synthesis and use thereof
10/04/2012WO2012129914A1 3-amino-2-hydroxy-4-phenyl-valyl-isoleucine and preparation method and use thereof
10/04/2012WO2012129859A1 Polyamine compounds and preparative mentods and uses thereof
10/04/2012WO2012129802A1 Pyrano[3,2-d]thiazol derivatives and uses as selective glycosidase inhibitors thereof
10/04/2012WO2012129792A1 Pyrimidinone compounds, preparation methods, pharmaceutical compositions and uses thereof
10/04/2012WO2012129765A1 Method for preparing stable-type vitamin a microcapsules continuously
10/04/2012WO2012129759A1 Oral dosage formulations containing both immediate-release and sustained-release drugs for treating neurodegenerative disorders
10/04/2012WO2012129702A1 Carbonyl containing compounds for controlling and repelling cimicidae populations
10/04/2012WO2012129680A1 Prodrugs of d-gamma-glutamyl-d-tryptophan and d-gamma- glutamyl-l-tryptophan
10/04/2012WO2012129673A1 INHIBITORS OF 17ß-HSD1, 17ß-HSD3 AND 17ß-HSD10
10/04/2012WO2012129651A1 Selective glycosidase inhibitors and uses thereof
10/04/2012WO2012129629A1 Active fraction of paullinia cupana with improved activity against fatigue, method for producing an active fraction, use, pharmaceutical composition, medicament and method for the treatment of fatigue
10/04/2012WO2012129589A1 Connective tissue monitoring, compositions for connective tissue treatment and methods for treating connective tissue
10/04/2012WO2012113802A1 Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles
10/04/2012WO2012110770A3 Combination of glycopyrrolate and a beta2 -agonist
10/04/2012WO2012109329A3 Methods for treatment of melanoma
10/04/2012WO2012106461A9 Combination therapy for treatment of cancer
10/04/2012WO2012106393A3 Withanolide isolated from physalis longifolia and analogs and methods of use thereof
10/04/2012WO2012106343A3 Hdac inhibitors and therapeutic methods using the same
10/04/2012WO2012104641A3 Pharmaceutical formulation
10/04/2012WO2012098172A3 N-arylaminomethylene benzothiophenones for treatment of cardiovascular disease
10/04/2012WO2012097121A9 Specific nnos inhibitors for the therapy and prevention of human melanoma
10/04/2012WO2012096458A3 Process for preparation of phenyl carbamate derivatives
10/04/2012WO2012095509A8 Composition for accelerating alcohol metabolism and for reducing the risk of alcohol induced diseases
10/04/2012WO2012092471A3 Novel tubulin inhibitors and methods of using the same
10/04/2012WO2012092202A9 Modulation of side effect profile of 5-alpha reductase inhibitor therapy
10/04/2012WO2012090219A3 Thiazole compounds useful as acetyl-coa carboxylase (acc) inhibitors
10/04/2012WO2012090201A4 Methods of improving cognitive function
10/04/2012WO2012090179A3 Isoquinoline derivatives as cannabinoid receptor modulators
10/04/2012WO2012087040A3 Conjugate for photodynamic diagnosis or therapy and method for preparing same
10/04/2012WO2012081908A3 Rna aptamer for teiocoic acid in staphylococcus aureus
10/04/2012WO2012081906A3 Rna aptamer for binding to ompc protein in salmonella tiphimirium strain
10/04/2012WO2012081036A3 A process for preparation of 4,4'-(1-methyl-1,2-ethandiyl)-bis-(2,6-piperazinedione)
10/04/2012WO2012081035A3 A process for preparation of praziquantel
10/04/2012WO2012079578A8 Selective killing of cancer cells
10/04/2012WO2012078667A3 Compositions and methods relating to proliferative diseases
10/04/2012WO2012077136A3 Process for the preparation of benzimidazole derivatives and its salts
10/04/2012WO2012077135A3 Substituted 4-(arylamino) selenophenopyrimidine compounds and methods of use thereof
10/04/2012WO2012071238A3 Treatment of nanog related diseases by inhibition of natural antisense transcript to nanog
10/04/2012WO2012071027A3 Nutraceutical based topical anxiolytic agent and method of use
1 ... 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 ... 7860